US2014051853A1PendingUtilityA1

Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide

Assignee: BUERGER HANS MICHAELPriority: Feb 4, 2004Filed: Jul 19, 2013Published: Feb 20, 2014
Est. expiryFeb 4, 2024(expired)· nominal 20-yr term from priority
A61P 35/00A61P 35/02A61P 35/04C07D 401/04C07D 401/14
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to acid addition salts of 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide, which are selected from the group consisting of a tartrate salt, such as a (D)(−) tartrate salt or a (L)(+) tartrate salt, a hydrochloride salt, a citrate salt, a malate salt, a fumarate salt, a succinate salt, a benzoate salt, a benzenesulfonate salt, a pamoate salt, a formate salt, a malonate salt, a 1,5-naphthalenedisulfonate salt, a salicylate salt, a cyclohexanesulfamate salt, a lactate salt, a mandelate salt, aq glutarate salt, an adipate salt, a squarate salt, a vanillate salt, an oxaloacetate salt, an ascorbate salt and a sulfate salt.

Claims

exact text as granted — not AI-modified
1 : An acid addition salt selected from the group consisting of imatinib ascorbate, imatinib formate, imatinib malonate, imatinib oxaloacetate, imatinib squarate and imatinib vanillate.

Join the waitlist — get patent alerts

Track US2014051853A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.